New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

Unlike other forms of blood cancer, acute myeloid leukemia (AML) cannot currently be treated with CAR-T cell immunotherapy. The reason is that specific molecular targets with which certain immune cells could specifically target AML cells are lacking, which would permit the immune system to attack cancer.

Leave A Comment

Your email address will not be published. Required fields are marked *